⌘K

Login Start Free

Home/Filings/4/0002001011-25-000061

4//SEC Filing

Reardon Andrew 4

Accession 0002001011-25-000061

CIK 0000886163other

View on SEC.gov Company Profile

Filed

Aug 11, 8:00 PM ET

Accepted

Aug 12, 4:34 PM ET

Size

4.7 KB

Accession

0002001011-25-000061

Insider Transaction Report

Form 4

Period: 2025-08-10

LIGAND PHARMACEUTICALS INCLGND

CLO & Secretary

Transactions

Tax Payment
Common Stock
2025-08-10$150.06/sh−1,325$198,830→ 30,811 total

Footnotes (1)

[F1]Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.

Documents

1 file

4
edgardoc.xmlPrimary
PRIMARY DOCUMENT

Issuer

LIGAND PHARMACEUTICALS INC

CIK 0000886163

Entity typeother

Related Parties

1

filerCIK 0001950232

Filing Metadata

Form type: 4
Filed: Aug 11, 8:00 PM ET
Accepted: Aug 12, 4:34 PM ET
Size: 4.7 KB

View on SEC.gov